UNSPSC 41202030: Herpes simplex virus serological assays

In this classification, Herpes simplex virus serological assays are devices used in test to identify specific Herpes simplex virus serological assays antibodies in serum. US FDA regulates Herpes simplex virus serological assays under 21 CFR 866.3305 and under FDA product code GQN.

UNSPSC 41202030 Herpes simplex virus serological assays is a Commodity code that encompasses blood- and specimen-based diagnostic testing supplies and related laboratory services for infectious disease screening, particularly sexually transmitted infections and public health surveillance. State and local procurement under this code spans serological test kits, reagents, controls, calibrators, consumables compatible with automated analyzer platforms, and ancillary laboratory testing services including specimen collection, specimen processing, and result reporting. The recent solicitation activity reflects actual buying of HIV test kits, syphilis reagents, gonorrhea/chlamydia (NG/CT) testing supplies, and drug-screening laboratory services rather than herpes simplex virus testing in particular; the code is being applied to a broader class of serology and diagnostic assays used in public health and criminal justice drug-monitoring contexts. Issuing bodies include state departments of public health (Illinois Department of Public Health Division of Laboratories), county health and community supervision departments (Collin County Community Supervision and Corrections Department, Collin County Health Care Services), city public health programs (City of Austin Public Health), county public safety procurement (Gwinnett County), and state criminal justice agencies (Texas Department of Criminal Justice). Illinois IDPH and Collin County appear as repeat buyers with multiple solicitations in the recent window.

Activity concentrates in Texas (Collin County, Gwinnett County, Texas Department of Criminal Justice) and Illinois (Illinois Department of Public Health), with additional activity from Austin. Representative recent opportunities include the Illinois Department of Public Health change order (Contract 68500013N, IFB, posted September 29, 2026, due October 13, 2026) increasing Hologic NG/CT testing volume from 15,000 to 25,000 annual tests and kits from 15,000 to 30,000 units, raising total contract cost from $525,000 to $900,000 over five years; Collin County Community Supervision and Corrections Department RFP 2026-327 (posted September 25, 2026, due July 23, 2026) for offender specimen collection and drug testing services covering approximately 25,031 annual tests with an estimated value of $600,000 over two years plus three optional renewals; and City of Austin IFB 9100 AAM1023 REBID (posted August 10, 2026, due September 3, 2026) for rapid HIV Type 1/2 test kits at approximately 375 units annually. Illinois IDPH also conducted sole-source emergency procurements with Abbott Laboratories for HIV/Syphilis reagents and Abbott ARCHITECT analyzer consumables totaling $38,079.50 (posted May 5 and May 21, 2026). Specimen collection and drug-testing services dominate recent volume alongside test-kit procurement for public health and criminal justice applications.